Article

A Meta-Analysis of the Sensitivity of Various Neuropsychological Tests Used to Detect Chemotherapy-Induced Cognitive Impairment in Patients With Breast Cancer

Catherine E. Jansen

Christine Miaskowski

Marylin Dodd

Glenna Dowling

sensitivity, psychological intervention, meta-analysis
ONF 2007, 34(5), 997-1005. DOI: 10.1188/07.ONF.997-1005

Purpose/Objectives: To identify which neuropsychological tests have been used to evaluate chemotherapy-induced impairment in various domains of cognitive function in patients with breast cancer and to determine the sensitivity of each of the tests through estimation of effect size.

Data Sources: Original studies published from 1966-June 2006.

Data Synthesis: Although an array of neuropsychological tests are available to measure the various domains of cognitive function, information is lacking regarding the sensitivity and specificity of the tests to detect changes in cognitive function from chemotherapy.

Conclusions: This meta-analysis provides initial data on the sensitivity of some neuropsychological tests to determine chemotherapy-induced changes in cognitive function in patients with breast cancer.

Implications for Nursing: The identification of sensitive neuro-psychological tests is crucial to further understanding of chemotherapy-induced cognitive impairments.

Jump to a section

    References

    Ahles, T.A., Saykin, A.J., Furstenberg, C.T., Cole, B., Mott, L.A., Skalla, K., et al. (2002). Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology, 20, 485-493.
    Ahles, T.A., Tope, D.M., Furstenberg, C., Hann, D., & Mills, L. (1996). Psychological and neuropsychologic impact of autologous bone marrow transplantation. Journal of Clinical Oncology, 14, 1457-1462.
    Anderson-Hanley, C., Sherman, M.L., Riggs, R., Agocha, V.B., & Compas, B.E. (2003). Neuropsychological effects of treatments for adults with cancer: A meta-analysis and review of the literature. Journal of the International Neuropsychological Society, 9, 967-982.
    Bender, C.M., Sereika, S.M., Berga, S.L., Vogel, V.G., Brufsky, A.M., Paraska, K.K., et al. (2006). Cognitive impairment associated with adjuvant therapy in breast cancer. Psycho-Oncology, 15, 422-430.
    Brezden, C.B., Phillips, K.A., Abdolell, M., Bunston, T., & Tannock, I.F. (2000). Cognitive function in breast cancer patients receiving adjuvant chemotherapy. Journal of Clinical Oncology, 18, 2695-2701.
    Castellon, S.A., Ganz, P.A., Bower, J.E., Petersen, L., Abraham, L., & Greendale, G.A. (2004). Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. Journal of Clinical and Experimental Neuropsychology, 26, 955-969.
    Chouinard, M.J., & Braun, C.M. (1993). A meta-analysis of the relative sensitivity of neuropsychological screening tests. Journal of Clinical and Experimental Neuropsychology, 15, 591-607.
    Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates.
    Cole, R.P., Scialla, S.J., & Bednarz, L. (2000). Functional recovery in cancer rehabilitation. Archives of Physical Medicine and Rehabilitation, 81, 623-627.
    Cull, A., Hay, C., Love, S.B., Mackie, M., Smets, E., & Stewart, M. (1996). What do cancer patients mean when they complain of concentration and memory problems? British Journal of Cancer, 74, 1674-1679.
    Donovan, K.A., Small, B.J., Andrykowski, M.A., Schmitt, F.A., Munster, P., & Jacobsen, P.B. (2005). Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer, 104, 2499-2507.
    Falleti, M.G., Sanfilippo, A., Maruff, P., Weih, L., & Phillips, K.A. (2005). The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: A meta-analysis of the current literature. Brain and Cognition, 59(1), 60-70.
    Freeman, J.R., & Broshek, D.K. (2002). Assessing cognitive dysfunction in breast cancer: What are the tools? Clinical Breast Cancer, 3(Suppl. 3), S91-S99.
    Gazzaniga, M.S., Ivry, R.B., & Mangun, G.R. (2002). Cognitive neuroscience: The biology of the mind (2nd ed.). New York: Norton.
    Glass, G.V. (1976). Primary, secondary, and meta-analysis of research. Educational Researcher, 5(10), 3-8.
    Grober, S.E. (2002). Resources for treatment of chemotherapy-related cognitive difficulty. Cancer Practice, 10, 216-218.
    Hedges, L.V., & Olkin, I. (1985). Statistical methods for meta-analysis. San Diego, CA: Academic Press.
    Heilman, K.M., Valenstein, E., & Watson, R.T. (1997). Disorders of attention. In M.R. Trimble & J.L. Cummings (Eds.), Contemporary behavioral neurology (pp. 127-137). Boston: Butterworth-Heinemann.
    Irwig, L., Tosteson, A.N., Gatsonis, C., Lau, J., Colditz, G., Chalmers, T.C., et al. (1994). Guidelines for meta-analyses evaluating diagnostic tests. Annals of Internal Medicine, 120, 667-676.
    Johnson, B.T. (1993). DSTAT 1.10: Software for the meta-analytic review of research literature. Hillsdale, NJ: Lawrence Erlbaum.
    Lezak, M.D., Howieson, D.B., & Loring, D.W. (2004). Neuropsychological assessment (4th ed.). New York: Oxford University Press.
    Lipsey, M.W., & Wilson, D.B. (2001). Practical meta-analysis. London: Sage.
    Raffa, R.B., Duong, P.V., Finney, J., Garber, D.A., Lam, L.M., Mathew, S.S., et al. (2006). Is ‘chemo-fog’/‘chemo-brain’ caused by cancer chemotherapy? Journal of Clinical Pharmacy and Therapeutics, 31, 129-138.
    Schagen, S.B., van Dam, F.S., Muller, M.J., Boogerd, W., Lindeboom, J., & Bruning, P.F. (1999). Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer, 85, 640-650.
    Scherwath, A., Mehnert, A., Schleimer, B., Schirmer, L., Fehlauer, F., Kreienberg, R., et al. (2006). Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: Evaluation of long-term treatment effects. Annals of Oncology, 17, 415-423.
    Shilling, V., Jenkins, V., Morris, R., Deutsch, G., & Bloomfield, D. (2005). The effects of adjuvant chemotherapy on cognition in women with breast cancer—Preliminary results of an observational longitudinal study. Breast, 14, 142-150.
    Shadish, W.R., & Haddock, C.K. (1994). Combining estimates of effect size. In H. Cooper & L.V. Hedges (Eds.). Handbook of research synthesis (pp. 261-282). New York: Russell Sage Foundation.
    Spreen, O., & Strauss, E. (1998). A compendium of neuropsychological tests: Administration, norms, and commentary (2nd ed.). New York: Oxford University Press.
    Stewart, A., Bielajew, C., Collins, B., Parkinson, M., & Tomiak, E. (2006). A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clinical Neuropsychologist, 20, 76-89.
    Tchen, N., Juffs, H.G., Downie, F.P., Yi, Q.L., Hu, H., Chemerynsky, I., et al. (2003). Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. Journal of Clinical Oncology, 21, 4175-4183.
    van Dam, F.S., Schagen, S.B., Muller, M.J., Boogerd, W., vd Wall, E., Droogleever Fortuyn, M.E., et al. (1998). Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy. Journal of the National Cancer Institute, 90, 210-218.
    Wefel, J.S., Lenzi, R., Theriault, R.L., Davis, R.N., & Meyers, C.A. (2004). The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized, longitudinal trial. Cancer, 100, 2292-2299.
    Wieneke, M.M., & Dienst, E.R. (1995). Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology, 4, 61-66.
    Wolf, F.M. (1986). Meta-analysis. Sage University Paper Series on Quantitative Applications in the Social Sciences [Series no. 07-001]. Beverly Hills, CA: Sage.
    Zakzanis, K.K. (2001). Statistics to tell the truth, the whole truth, and nothing but the truth: Formulae, illustrative numerical examples, and heuristic interpretation of effect size analyses for neuropsychological researchers. Archives of Clinical Neuropsychology, 16, 653-667.